Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Jobe

Hand Surgery Austin, TX Medical Doctor

NPI 1487882296 CMS profile 633242

4310 James Casey St, Suite 3C, Austin, TX 78745

Open in the dashboard

General payments

$10,210

73 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeffrey Jobe of Austin, TX is reported in the CMS Open Payments database as having received $10,210 across 73 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $485 4
2024 General $429 5
2023 General $483 5
2022 General $549 9
2021 General $2,009 16
2020 General $5,671 13
2019 General $583 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Jobe
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Jeffrey Jobe were reported at $485. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Jeffrey Jobe Hand Surgery median Middle half National median
2019 $583 $383 $106–$1,905 $163
2020 $5,671 $172 $51–$1,268 $114
2021 $2,009 $263 $71–$1,591 $132
2022 $549 $336 $87–$1,938 $149
2023 $483 $233 $81–$1,114 $160
2024 $429 $258 $88–$1,203 $164
2025 $485 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $5,855 7 payments
  2. Acumed LLC $2,355 11 payments
  3. Abbott Laboratories $1,376 23 payments
  4. Medartis Inc. $142 1 payment
  5. Endo Pharmaceuticals Inc. $109 7 payments
  6. AxoGen $88 3 payments
  7. Linvatec Corporation $39 1 payment
  8. DePuy Synthes Sales Inc. $38 2 payments
  9. Bioventus LLC $30 2 payments
  10. Orthofix Medical, Inc. $28 7 payments
  11. Other $149 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $5,500 2 payments
  2. Food and Beverage $3,270 69 payments
  3. Travel and Lodging $1,440 2 payments
Products named General payments · program years 2019–2025
  1. TITAN-SHOULDER $5,855 7 payments
  2. FREEDOM WRIST $5,855 7 payments
  3. EXTERNAL FIXATION SYSTEM $5,855 7 payments
  4. REVERSE SHOULDER $5,500 2 payments
  5. Ankle Plating System $1,487 4 payments
  6. OCTRODE $731 10 payments
  7. Elbow Plating System $508 3 payments
  8. Clavicle Plating System $508 3 payments
  9. Calcaneal Plating System $508 3 payments
  10. Scapula Plating System $508 3 payments
  11. Other $3,161 71 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

220

Median for Hand Surgery: 118

Drug cost

$937

Median for Hand Surgery: $615

Branded share of claims

65.9%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 115 $630
Cephalexin Generic 48 $122
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 12 $93
Acetaminophen-Codeine Acetaminophen With Codeine Brand 18 $58
Tramadol Hcl Generic 12 $20
Meloxicam Generic 15 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$174,550

Of which drugs: $4,347

Medicare patients

496

Average age 73

Services billed

2,834

278 women, 218 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 62%
Ischemic heart disease 33%
Diabetes 22%
Depression 21%
Atrial fibrillation 16%
Chronic kidney disease 16%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 237 1,458 $1,044

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

73 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record